Complementary & Alternative Medicine for Mental Health

(sharon) #1

  1. EFFICACY: MONOTHERAPY AND ADJUNCTIVE USE FOR ANXIETY AND DEPRESSION: There
    are insufficient data to recommend use of tryptophan or 5-HTP, but there is enough
    promise to merit further research and to advise consumers using tryptophan or 5-HTP of
    the promising evidence that exists. Though the list of noted drug interactions and side
    effects is still short, it will grow longer as we learn more about 5-HTP and tryptophan. So a
    consumer must decide whether to take 5-HTP or tryptophan now because it is promising, or
    later, when science knows enough to make the call and more information is available. If you
    are under a physician’s care, and especially if you are taking psychotropic medicine, you
    definitely should talk with your medical doctor before trying adjunctive supplementation
    with 5-HTP or tryptophan.
     Although only five of eleven controlled studies showed statistically significant
    improvement, according to Brown et al., increasing numbers of consumers are using 5 -
    HTP as a treatment for depression.
     Lake and Spiegel (through Settle, J.E.) cite the double-blind study by Kahn et al. (1985,
    1987), which showed significant improvement in anxiety symptoms, but not
    depression 5 - HTP was as good as clomipramine (Anafranil) for anxiety, but less effective
    for depression.^1
     As early as 1976, Walinder et al.^2 found that 24 depressed patients started on
    clomipramine (Anafranil), an older tricyclic antidepressant, improved more rapidly with
    tryptophan supplementation. There are also considerable data suggesting that
    tryptophan depletion can increase depressive symptoms in patients with major
    depression and seasonal affective disorder. Subsequent reversal of depression with
    intravenous tryptophan supports the notion of an antidepressant effect. No interaction
    was noted with tricyclic anti-depressants.
     Lake and Spiegel (through Settle, J.E.) state flatly that the existing research on 5-HTP is
    flawed by small sample sizes, uncontrolled study conditions and heterogeneous study
    populations. Reports of a 20% relapse rate after the first month of treatment makes
    longer studies essential in assessing the efficacy of 5-HTP.

Free download pdf